alexa
Reach Us +1 218 451 2974
Effective Treatments For Addiction And Comorbid Psychiatric Disorders | 8742
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Effective treatments for addiction and comorbid psychiatric disorders

2nd International Conference and Exhibition on Addiction Research & Therapy

Thomas M. Kelly

ScientificTracks Abstracts: J Addict Res Ther

DOI: 10.4172/2155-6105.S1.011

Abstract
R espected investigators suggest that addiction is multiply determined and cannot be adequately treated using the narrow biomedical model of prescribing one medication or one psychosocial treatment. They recommend integrating evidence- based treatments because combining distinct but compatible treatments creates a synergistic effect that increases treatment effectiveness. Highly effective treatments are especially needed among patients with co-occurring psychiatric disorders because comorbidity impedes recovery. One clinical trial by the National Institute on Drug Abuse Clinical Trials Network used a 12-Step facilitative intervention in a dual disorders addiction clinic. Entitled Stimulant Abuse Groups to Engage in 12-Step Programs (STAGE-12), the intervention was added to Intensive Outpatient Therapy (IOP) and compared to IOP alone (Treatment As Usual, TAU) (N=421). Compared to TAU, STAGE-12 participants had greater odds of being stimulant abstinent during the 8-week treatment phase. However, among STAGE-12 participants, those who had not achieved abstinence reported more drug use. STAGE-12 participants had lower drug- related consequences on the Addiction Severity Index (ASI) than TAU participants. No other differences were found. Another study at the University of Pittsburgh Medical Center investigated the affect of a Contingency Management (CM) intervention during IOP (N=160). Participants were systematically exposed, or not exposed to a CM intervention for one year. Participants exposed to CM spent more time in IOP treatment. Importantly, time in treatment mediated the relationship between exposure to CM and drug free days. Although the findings are not consistently positive, outcomes from these studies indicate that combining other treatments with IOP can be more effective than IOP alone
Biography
Thomas M. Kelly earned his Ph.D. at the University of Pittsburgh in 1996 and is an Associate Professor of Psychiatry at the University of Pittsburgh School of Medicine. He is currently Director of the Adolescent Substance Abuse Treatment Service at the University of Pittsburgh Medical Center and is a Co-Investigator with the Appalachian Tri-States Node of the National Institute on Drug Abuse Clinical Trials Network. He has conducted research among adolescents with alcohol-related injuries and among adults with dual substance and psychiatric disorders. He has published over 20 first- authored papers in the fields of psychiatry and addiction
Relevant Topics
Top